{"entity":{"type":"insider","cik":"0001585669","url":"/insider/0001585669","json_url":"/insider/0001585669.json","name":"Vanover Kimberly E.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":6,"first":"2016-12-19","last":"2019-01-08","span_basis":"filed_date"},"name_variants":[{"name":"Vanover Kimberly E.","source":"filing","n_filings":6,"first_seen":"2016-12-19","last_seen":"2019-01-08"}],"transactions":[{"id":8188924,"accession":"0001209191-19-002957","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-002957","line_url":"/filing/0001209191-19-002957#line-4","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585669","owner_name":"Vanover Kimberly E.","owner_display_name":"Vanover Kimberly E.","owner_url":"/insider/0001585669","role":"Officer (SVP, Early Stage Clinical Dev)","role_mark":"O","role_mark_label":"Officer (SVP, Early Stage Clinical Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Early Stage Clinical Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":592.0,"shares_display":"592","price_per_share":12.29,"price_display":"12.29","price_state":"stated","total_value":7275.68,"total_display":"7,275.68","total_whole":"7,276","shares_owned_after":27068.0,"shares_owned_after_display":"27,068","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-07","filed_date":"2019-01-08","scope":"insider"},{"id":8188919,"accession":"0001209191-19-002957","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-002957","line_url":"/filing/0001209191-19-002957","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585669","owner_name":"Vanover Kimberly E.","owner_display_name":"Vanover Kimberly E.","owner_url":"/insider/0001585669","role":"Officer (SVP, Early Stage Clinical Dev)","role_mark":"O","role_mark_label":"Officer (SVP, Early Stage Clinical Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Early Stage Clinical Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9564.0,"shares_display":"9,564","price_per_share":11.47047678795483,"price_display":"11.47","price_state":"stated","total_value":109703.64,"total_display":"109,703.64","total_whole":"109,704","shares_owned_after":29844.0,"shares_owned_after_display":"29,844","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-04","filed_date":"2019-01-08","scope":"insider","n_lines":2},{"id":7944731,"accession":"0001209191-19-001588","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-001588","line_url":"/filing/0001209191-19-001588#line-2","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585669","owner_name":"Vanover Kimberly E.","owner_display_name":"Vanover Kimberly E.","owner_url":"/insider/0001585669","role":"Officer (SVP, Early Stage Clinical Dev)","role_mark":"O","role_mark_label":"Officer (SVP, Early Stage Clinical Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Early Stage Clinical Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4834.0,"shares_display":"4,834","price_per_share":11.1,"price_display":"11.10","price_state":"stated","total_value":53657.4,"total_display":"53,657.40","total_whole":"53,657","shares_owned_after":16861.0,"shares_owned_after_display":"16,861","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-02","filed_date":"2019-01-03","scope":"insider"},{"id":6349550,"accession":"0001209191-18-003212","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-003212","line_url":"/filing/0001209191-18-003212#line-1","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585669","owner_name":"Vanover Kimberly E.","owner_display_name":"Vanover Kimberly E.","owner_url":"/insider/0001585669","role":"Officer (SVP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":772.0,"shares_display":"772","price_per_share":17.46,"price_display":"17.46","price_state":"stated","total_value":13479.12,"total_display":"13,479.12","total_whole":"13,479","shares_owned_after":12373.0,"shares_owned_after_display":"12,373","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-08","filed_date":"2018-01-10","scope":"insider"},{"id":6656868,"accession":"0001209191-18-002599","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-002599","line_url":"/filing/0001209191-18-002599#line-3","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585669","owner_name":"Vanover Kimberly E.","owner_display_name":"Vanover Kimberly E.","owner_url":"/insider/0001585669","role":"Officer (SVP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1185.0,"shares_display":"1,185","price_per_share":17.37,"price_display":"17.37","price_state":"stated","total_value":20583.45,"total_display":"20,583.45","total_whole":"20,583","shares_owned_after":13145.0,"shares_owned_after_display":"13,145","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-05","filed_date":"2018-01-05","scope":"insider"},{"id":4153717,"accession":"0001209191-17-003002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-003002","line_url":"/filing/0001209191-17-003002#line-1","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585669","owner_name":"Vanover Kimberly E.","owner_display_name":"Vanover Kimberly E.","owner_url":"/insider/0001585669","role":"Officer (SVP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":16.59,"price_display":"16.59","price_state":"stated","total_value":13272.0,"total_display":"13,272.00","total_whole":"13,272","shares_owned_after":10128.0,"shares_owned_after_display":"10,128","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-05","filed_date":"2017-01-09","scope":"insider"},{"id":2969155,"accession":"0001209191-16-155989","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-16-155989","line_url":"/filing/0001209191-16-155989","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585669","owner_name":"Vanover Kimberly E.","owner_display_name":"Vanover Kimberly E.","owner_url":"/insider/0001585669","role":"Officer (SVP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9375.0,"shares_display":"9,375","price_per_share":15.229106666666667,"price_display":"15.23","price_state":"stated","total_value":142772.875,"total_display":"142,772.88","total_whole":"142,773","shares_owned_after":7500.0,"shares_owned_after_display":"7,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-15","filed_date":"2016-12-19","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001567514","name":"Intra-Cellular Therapies, Inc.","url":"/issuer/0001567514","role":"Officer (SVP, Early Stage Clinical Dev)","n_filings":6,"first_seen":"2016-12-19","last_seen":"2019-01-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001585669","retrieved_at":"2026-08-22T22:11:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}